You are here: Industry Insights > innovation

News List

20 Years of Growth and Innovation in China, Fette Compacting Launches F30p Tablet Press PharmaSources
December 13, 2024
Interview Dr. Andreas Risch——Managing Director of Fette Compacting (China) Co., Ltd.
Global Drug Innovation Trend and Its Market Landscape Shruiti Talashi
September 25, 2024
The creation of novel medications, treatments, and medical equipment that improve patient care and treatment results or outcomes is referred to as pharmaceutical innovation.
Process Optimization and Cost Control of Targeted Drugs: Accelerating Innovation in Biopharmaceuticals David Orchard-Webb
September 03, 2024
In today's competitive drug development market, biopharmaceutical businesses are always under pressure to provide high-quality medicines swiftly and affordably.
The Rapidly Expanding Global Weight Loss Market and the Role of Chinese Innovations PharmaSources/ChatGPT
August 28, 2024
The trend highlights China’s growing influence in the global pharmaceutical landscape and its increasing role in advancing global health solutions.
Drug Apocalypse of the Future: Artificial Intelligence Discovers New Antibiotics, Disrupting Traditional Innovations Big Cat of Medical Field
March 11, 2024
At present, the use of artificial intelligence to participate in the discovery and design of new drugs has become a hot track for new drug research and development.
BD to Highlight its Deep Commitment to Drug Delivery Innovation at Pharmapack B3C newswire
January 15, 2024
A leading global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place on January 24-25, 2024 at Paris Expo, Porte de Versailles, in Paris.
Flexible Production in the Pharmaceutical Industry: Navigating the Dynamics of Innovation David Orchard-Webb
January 02, 2024
The pharmaceutical industry, with its complex and dynamic landscape, is witnessing a paradigm shift in its manufacturing strategies.
Chinese Produced ASO Drug Innovation Therapy for Functional Cure of Chronic Hepatitis B Has Obtained FDA Clinical Approval Xiaoyaowan/Pharmasources
September 08, 2023
Recently, Haobo Pharmaceuticals announced that their investigational antisense oligonucleotide (ASO) drug AHB-137 has received clinical trial approval from the FDA in the United States for use in patients with chronic hepatitis B.
FTC’s Antitrust Intensifies, Where Does Pharmaceutical Innovation Go? PharmaSources/Xiaobing
August 23, 2023
In fact, the FTC has more than once blocked MNC’s mergers and acquisitions under the name of “antitrust”. So, what impact will this have on the US pharmaceutical ecosystem? What challenges does it pose to domestic innovative drugs going global?
Rec-Biotechnology Went to Hong Kong, S.A.R., China IPO, Aiming at the HPV Vaccine Market Worth Tens of Billions and Creating an Innovation Engine of Comprehensive Vaccine PharmaSources/Yefenghong
August 02, 2021
On July 16, Rec-Biotechnology submitted its prospectus to HKEX and was accepted. Rec-Biotechnology is an innovative vaccine company, and its core product, Human Papillomavirus 9-valent Vaccine, Recombinant, is in Phase III clinical trial stage.